This sensitivity is likely not restricted to BRCA1/2-mutated breast cancers, as it is thought that up to 30% of sporadic (germline BRCA wild-type) breast cancers have defects in homologous recombination repair, a phenotype that is often referred to as ‘BRCAness’ [12]. This evidence concerns the gene BRCA1 and breast carcinoma.